Azilect Review

Product Features

Azilect is the brand name under which the single active ingredient called Rasagiline is marketed. An Azilect generic product seems to have been approved by the FDA, while other brands also commercialize products based on this chemical.
This compound is an irreversible monoamine oxidase type-B inhibitor (MAO-B). It is a common treatment prescribed for Parkinson’s disease. This condition is a chronic and progressive disorder known to be caused by reduced Dopamine levels in the brain. Rasagiline is also researched as a treatment for another neurodegenerative disorder called Alzheimer’s disease. The main advertised benefits of this inhibitor target enhancing memory, including in people who suffer from age-related memory decline, enhancing mood and increasing learning ability. Some of the most significant and severe symptoms of the disease involve incontrolable movement. These symptoms may manifest as shakiness, slowness, stiffness and even difficulty in walking. Azilect (Rasagiline) is capable to inhibit the action of the MAO-B enzyme which is responsible for the breaking down of Dopamine. This way, the neurotransmitter is able to enter the BBB (blood-brain barrier) and to accomplish its many important roles including in maintaining proper coordination and mobility.

One of Azilect’s most concerning side effects refers to it potentially increasing the risk of skin cancer, particularly in patients with Parkinson’s. However, this concern has not been supported by clinical evidence and the FDA approved this medication in the treatment of this disease. Other Azilect side effects mentioned by the manufacturer include flu syndrome, joint pain, indigestion, and depression. As an adjunct therapy, the drug may lead to dyskinesia, weight loss, vomiting, nausea, constipation, and others (all mentioned on the official page). The Azilect drug interactions include other MAOIs, meperidine, tramadol, methadone, propoxyphene or St. John’s wort.

People who suffer from moderate to severe liver disease should not use this medication.
The suggested doe is 1 pill once daily, with or without food.

Conclusion

The Azilect drug is designed as a support in the treatment of a common degenerative disorder affecting elder individuals called Parkinson’s disease. The product is advertised to be helpful in relieving the symptoms involving mobility in these patients. This is one of the most common symptoms associated with the condition.
A study involving this drug has shown that the product is effective in increasing the available synaptic Dopamine with no significant adverse reactions as compared to placebo drugs. However, there are other clinical studies that failed to show such promising results. Based on these trials, some researchers have issued the statement that further research is needed before drawing a medical-evidence consolidated conclusion.

In any case, the main aspect to be kept in mind is that this product may become very dangerous if combined with other drugs or if it is used by certain categories of people. For complete information about the safety of this medication it is imperative to consult a healthcare practitioner.